NC State’s Office of Technology Transfer (OTT) protects the University’s intellectual property (IP) while promoting the transfer of academic discovery to industry for public benefit and economic development.

Whether you need to complete an Invention Disclosure Form or are interested in licensing a university technology , our licensing and technology development staff is available to guide you through the technology transfer process.

Our website provides information and resources to get you started. We look forward to working with you.

BioMarck Receives FDA Approval for Phase II Trial of Lung Drug

February 4 , 2008 --

BioMarck, an NC State start-up company, has received clearance from the U.S. Food and Drug Administration to launch a Phase II clinical trial for its compound that targets chronic obstructive respiratory disease, or COPD.

The company's treatment for respiratory diseases is based on technology licensed from NC State.

Biolex Plans IPO

August 15, 2007 -- Biolex of Pittsboro, N.C., an NC State start-up company, filed plans with the Securities and Exchange Commission for an IPO.  

Biolex is developing experimental medicines, including a treatment for hepatitis C, using genetically engineered Lemna, an aquatic plant known as duckweed.